Makkah – Corporate Communications

King Abdullah Medical City (KAMC), a member of the Makkah Health Cluster, has launched a pioneering initiative at its Heart Center by introducing the CardioMEMS™ HF System, one of the world's most advanced FDA-approved technologies for remote monitoring of heart failure patients. This milestone reflects KAMC's commitment to advancing smart, proactive healthcare, improving patients' quality of life, and reducing complications associated with heart failure.

The CardioMEMS HF System continuously measures pulmonary artery pressure, enabling clinicians to detect early signs of worsening heart failure and fluid retention days—or even weeks—before clinical symptoms develop. This allows healthcare teams to intervene early, optimize treatment plans proactively, reduce hospital admissions, and improve overall clinical outcomes.

According to the clinical team, the technology is primarily intended for patients with New York Heart Association (NYHA) Class II and III heart failure, who are among those most likely to benefit from continuous hemodynamic monitoring to prevent disease progression.

The system consists of a miniature wireless sensor that is permanently implanted in the pulmonary artery through a minimally invasive right heart catheterization procedure. The sensor requires no batteries or wires. Patients also receive a next-generation home monitoring unit that enables them to take daily readings by simply lying on a specialized pillow for a few minutes. The collected data are transmitted wirelessly to the care team.

The pressure readings are securely uploaded to a cloud-based digital platform, allowing clinicians to review daily trends through detailed graphs and analytics. Based on these data, physicians can adjust diuretic therapy or other heart failure medications promptly, often without requiring an in-person clinic visit or waiting for symptoms to appear.

The medical team noted that published clinical studies have demonstrated the system's significant effectiveness, showing a 57%–69% reduction in heart failure-related hospitalizations, along with improved quality of life and fewer disease-related complications. These outcomes position CardioMEMS as one of the most innovative digital solutions for managing heart failure patients.

The introduction of this technology underscores King Abdullah Medical City's ongoing commitment to adopting cutting-edge medical innovations, digital health solutions, and artificial intelligence to enhance specialized healthcare services, elevate the patient experience, and support the objectives of the Health Sector Transformation Program and Saudi Vision 2030